欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称SonoVue
适用类别Human
治疗领域Ultrasonography;Echocardiography
通用名/非专利名称sulphur hexafluoride
活性成分sulphur hexafluoride
产品号EMEA/H/C/000303
患者安全信息No
许可状态Authorised
ATC编码V08DA05
是否额外监管No
是否仿制药或hybrid药物No
是否生物类似药No
是否附条件批准No
是否特殊情形No
是否加速审评No
是否罕用药No
上市许可日期2001/03/26
上市许可开发者/申请人/持有人Bracco International B.V.
人用药物治疗学分组Contrast media
兽用药物治疗学分组
欧盟委员会决定日期2022/11/10
修订号21
治疗适应症This medicinal product is for diagnostic use only. SonoVue is for use with ultrasound imaging to enhance the echogenicity of the blood, or of fluids in the urinary tract which results in an improved signal to noise ratio. SonoVue should only be used in patients where study without contrast enhancement is inconclusive. Echocardiography SonoVue is a transpulmonary echocardiographic contrast agent for use in adult patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation. Doppler of macrovasculature SonoVue increases the accuracy in detection or exclusion of abnormalities in cerebral arteries and extracranial carotid or peripheral arteries in adult patients by improving the Doppler signal to noise ratio. SonoVue increases the quality of the Doppler flow image and the duration of clinically useful signal enhancement in portal vein assessment in adult patients. Doppler of microvasculature SonoVue improves display of the vascularity of liver and breast lesions during Doppler sonography in adult patients leading to more specific lesion characterisation. Ultrasonography of excretory urinary tract SonoVue is indicated for use in ultrasonography of the excretory tract in paediatric patients from newborn to 18 years to detect vesicoureteral reflux. For the limitation in the interpretation of a negative urosonography.
适用物种
兽用药物ATC编码
首次发布日期2018/04/26
最后更新日期2025/11/24
产品说明书https://www.ema.europa.eu/en/documents/product-information/sonovue-epar-product-information_en.pdf
公共评估报告https://www.ema.europa.eu/en/medicines/human/EPAR/sonovue
©2006-2026 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase